Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma
Firoz Anwar,1 Fahad A Al-Abbasi,1 Salma Naqvi,2 Ryan Adnan Sheikh,1 Sultan Alhayyani,3 Amer H Asseri,1 Turky Omar Asar,1 Vikas Kumar4 1Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia; 2Department of Biomedical Sciences, College of Medicine, Gulf Medica...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-05-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/therapeutic-potential-of-nanomedicine-in-management-of-alzheimers-dise-peer-reviewed-fulltext-article-IJN |
| _version_ | 1797821695238602752 |
|---|---|
| author | Anwar F Al-Abbasi FA Naqvi S Sheikh RA Alhayyani S Asseri AH Asar TO Kumar V |
| author_facet | Anwar F Al-Abbasi FA Naqvi S Sheikh RA Alhayyani S Asseri AH Asar TO Kumar V |
| author_sort | Anwar F |
| collection | DOAJ |
| description | Firoz Anwar,1 Fahad A Al-Abbasi,1 Salma Naqvi,2 Ryan Adnan Sheikh,1 Sultan Alhayyani,3 Amer H Asseri,1 Turky Omar Asar,1 Vikas Kumar4 1Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia; 2Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates; 3Department of Chemistry, College of Sciences & Arts, Rabigh King Abdulaziz University, Jeddah, Saudi Arabia; 4Natural Product Discovery Laboratory, Department of Pharmaceutical Sciences, Shalom Institute of Health and Allied Sciences, SHUATS, Prayagraj, IndiaCorrespondence: Firoz Anwar; Vikas Kumar, Email fanwar1@kau.edu.sa; phvikas@gmail.comAbstract: Neoplasm (Glioblastoma) and Alzheimer’s disease (AD) comprise two of the most chronic psychological ailments. Glioblastoma is one of the aggressive and prevalent malignant diseases characterized by rapid growth and invasion resulting from cell migration and degradation of extracellular matrix. While the latter is characterized by extracellular plaques of amyloid and intracellular tangles of tau proteins. Both possess a high degree of resistance to treatment owing to the restricted transport of corresponding drugs to the brain protected by the blood–brain barrier (BBB). Development of optimized therapies using advanced technologies is a great need of today. One such approach is the designing of nanoparticles (NPs) to facilitate the drug delivery at the target site. The present article elaborates the advances in nanomedicines in treatment of both AD as well as Gliomas. The intention of this review is to provide an overview of different types of NPs with their physical properties emphasizing their importance in traversing the BBB and hitting the target site. Further, we discuss the therapeutic applications of these NPs along with their specific targets. Multiple overlapping factors with a common pathway in development of AD and Glioblastoma are discussed in details that will assist the readers in developing the conceptual approach to target the NP for an aging population in the given circumstances with limitations of currently designed NPs, and the challenges to meet and the future perspectives.Keywords: therapeutic potential, Alzheimer’s disease, glioma, nanomedicine, blood–brain barrier |
| first_indexed | 2024-03-13T09:56:35Z |
| format | Article |
| id | doaj.art-5a69e8d94edd4e55a4707bef84d836a8 |
| institution | Directory Open Access Journal |
| issn | 1178-2013 |
| language | English |
| last_indexed | 2024-03-13T09:56:35Z |
| publishDate | 2023-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of Nanomedicine |
| spelling | doaj.art-5a69e8d94edd4e55a4707bef84d836a82023-05-23T18:52:21ZengDove Medical PressInternational Journal of Nanomedicine1178-20132023-05-01Volume 182737275683887Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and GliomaAnwar FAl-Abbasi FANaqvi SSheikh RAAlhayyani SAsseri AHAsar TOKumar VFiroz Anwar,1 Fahad A Al-Abbasi,1 Salma Naqvi,2 Ryan Adnan Sheikh,1 Sultan Alhayyani,3 Amer H Asseri,1 Turky Omar Asar,1 Vikas Kumar4 1Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia; 2Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates; 3Department of Chemistry, College of Sciences & Arts, Rabigh King Abdulaziz University, Jeddah, Saudi Arabia; 4Natural Product Discovery Laboratory, Department of Pharmaceutical Sciences, Shalom Institute of Health and Allied Sciences, SHUATS, Prayagraj, IndiaCorrespondence: Firoz Anwar; Vikas Kumar, Email fanwar1@kau.edu.sa; phvikas@gmail.comAbstract: Neoplasm (Glioblastoma) and Alzheimer’s disease (AD) comprise two of the most chronic psychological ailments. Glioblastoma is one of the aggressive and prevalent malignant diseases characterized by rapid growth and invasion resulting from cell migration and degradation of extracellular matrix. While the latter is characterized by extracellular plaques of amyloid and intracellular tangles of tau proteins. Both possess a high degree of resistance to treatment owing to the restricted transport of corresponding drugs to the brain protected by the blood–brain barrier (BBB). Development of optimized therapies using advanced technologies is a great need of today. One such approach is the designing of nanoparticles (NPs) to facilitate the drug delivery at the target site. The present article elaborates the advances in nanomedicines in treatment of both AD as well as Gliomas. The intention of this review is to provide an overview of different types of NPs with their physical properties emphasizing their importance in traversing the BBB and hitting the target site. Further, we discuss the therapeutic applications of these NPs along with their specific targets. Multiple overlapping factors with a common pathway in development of AD and Glioblastoma are discussed in details that will assist the readers in developing the conceptual approach to target the NP for an aging population in the given circumstances with limitations of currently designed NPs, and the challenges to meet and the future perspectives.Keywords: therapeutic potential, Alzheimer’s disease, glioma, nanomedicine, blood–brain barrierhttps://www.dovepress.com/therapeutic-potential-of-nanomedicine-in-management-of-alzheimers-dise-peer-reviewed-fulltext-article-IJNtherapeutic potentialalzheimer’s diseasegliomananomedicineblood-brain barrier. |
| spellingShingle | Anwar F Al-Abbasi FA Naqvi S Sheikh RA Alhayyani S Asseri AH Asar TO Kumar V Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma International Journal of Nanomedicine therapeutic potential alzheimer’s disease glioma nanomedicine blood-brain barrier. |
| title | Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma |
| title_full | Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma |
| title_fullStr | Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma |
| title_full_unstemmed | Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma |
| title_short | Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma |
| title_sort | therapeutic potential of nanomedicine in management of alzheimer rsquo s disease and glioma |
| topic | therapeutic potential alzheimer’s disease glioma nanomedicine blood-brain barrier. |
| url | https://www.dovepress.com/therapeutic-potential-of-nanomedicine-in-management-of-alzheimers-dise-peer-reviewed-fulltext-article-IJN |
| work_keys_str_mv | AT anwarf therapeuticpotentialofnanomedicineinmanagementofalzheimerrsquosdiseaseandglioma AT alabbasifa therapeuticpotentialofnanomedicineinmanagementofalzheimerrsquosdiseaseandglioma AT naqvis therapeuticpotentialofnanomedicineinmanagementofalzheimerrsquosdiseaseandglioma AT sheikhra therapeuticpotentialofnanomedicineinmanagementofalzheimerrsquosdiseaseandglioma AT alhayyanis therapeuticpotentialofnanomedicineinmanagementofalzheimerrsquosdiseaseandglioma AT asseriah therapeuticpotentialofnanomedicineinmanagementofalzheimerrsquosdiseaseandglioma AT asarto therapeuticpotentialofnanomedicineinmanagementofalzheimerrsquosdiseaseandglioma AT kumarv therapeuticpotentialofnanomedicineinmanagementofalzheimerrsquosdiseaseandglioma |